- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Funmi Olopade Previews Her Keynote Address for SABCS
Funmi Olopade, MD, FACP, professor of medicine and human genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medical Center, previews her keynote address for the San Antonio Breast Cancer Symposium (SABCS).
Funmi Olopade, MD, FACP, professor of medicine and human genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medical Center, previews her SABCS keynote address on solidarity after the COVID-19 pandemic.
Transcript
As you think about your message for the keynote address at the San Antonio Breast Cancer Symposium (SABCS), what messages are you hoping to share with the attendees?
It's about solidarity; solidarity in access to clinical trials; solidarity in access to screening studies; solidarity in joining WISDOM wherever you are, so we can learn about the best way to screen women. It doesn't have to be that the US is the best way to go forward, because SABCS is going to have participants from all over the world. We can learn from all over the world who is doing best with controlling this pandemic. Certainly not the US—we've lost too many lives. And yet we have spent the most money on health care, so we can do better.
I hope that every one of us will go back to thinking about, what are the best practices globally and how can we use innovation going forward to accelerate progress? It's going to be innovation, science, and technology. Yes, we can do faith-based interventions, we can practice faith-based medicine, but we cannot continue to deny science. So, hopefully, science and technology would allow us to do better in the future.
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Safety and Efficacy Updates for Asthma and Urticaria Therapies
April 5th 2025The long-term safety and efficacy of omalizumab, alongside promising phase 3 trial results that demonstrated the efficacy and favorable hematological safety profile of remibrutinib, were highlighted at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
